188 related articles for article (PubMed ID: 2128616)
1. Prevention of calcification of glutaraldehyde pretreated bovine pericardium through controlled release polymeric implants: studies of Fe3+, Al3+, protamine sulphate and levamisole.
Pathak YV; Boyd J; Levy RJ; Schoen FJ
Biomaterials; 1990 Nov; 11(9):718-23. PubMed ID: 2128616
[TBL] [Abstract][Full Text] [Related]
2. Synergistic inhibition of the calcification of glutaraldehyde pretreated bovine pericardium in a rat subdermal model by FeCl3 and ethanehydroxydiphosphonate: preincubation and polymeric controlled release studies.
Hirsch D; Drader J; Pathak YV; Yee R; Schoen FJ; Levy RJ
Biomaterials; 1993 Jul; 14(9):705-11. PubMed ID: 8399967
[TBL] [Abstract][Full Text] [Related]
3. Initiation of mineralization in bioprosthetic heart valves: studies of alkaline phosphatase activity and its inhibition by AlCl3 or FeCl3 preincubations.
Levy RJ; Schoen FJ; Flowers WB; Staelin ST
J Biomed Mater Res; 1991 Aug; 25(8):905-35. PubMed ID: 1918108
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of mineralization of glutaraldehyde-pretreated bovine pericardium by AlCl3. Mechanisms and comparisons with FeCl3, LaCl3, and Ga(NO3)3 in rat subdermal model studies.
Webb CL; Schoen FJ; Flowers WE; Alfrey AC; Horton C; Levy RJ
Am J Pathol; 1991 Apr; 138(4):971-81. PubMed ID: 1901454
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of calcification of glutaraldehyde pretreated porcine aortic valve cusps with sodium dodecyl sulfate: preincubation and controlled release studies.
Hirsch D; Drader J; Thomas TJ; Schoen FJ; Levy JT; Levy RJ
J Biomed Mater Res; 1993 Dec; 27(12):1477-84. PubMed ID: 8113234
[TBL] [Abstract][Full Text] [Related]
6. Long-term anticalcification effect of Fe3+ in rat subdermal implants of glutaraldehyde preserved bovine pericardium.
Baldwin MT; Ciesliga BL; Barkasi LD; Webb CL
ASAIO Trans; 1991; 37(3):M170-2. PubMed ID: 1751096
[TBL] [Abstract][Full Text] [Related]
7. Al+++ binding studies and metallic cation effects on bioprosthetic heart valve calcification in the rat subdermal model.
Webb CL; Flowers WE; Boyd J; Rosenthal EL; Schoen FJ; Levy RJ
ASAIO Trans; 1990; 36(2):56-9. PubMed ID: 2340209
[TBL] [Abstract][Full Text] [Related]
8. Prevention of bioprosthetic heart valve calcification by ethanol preincubation. Efficacy and mechanisms.
Vyavahare N; Hirsch D; Lerner E; Baskin JZ; Schoen FJ; Bianco R; Kruth HS; Zand R; Levy RJ
Circulation; 1997 Jan; 95(2):479-88. PubMed ID: 9008467
[TBL] [Abstract][Full Text] [Related]
9. Controlled-release drug delivery of diphosphonates to inhibit bioprosthetic heart valve calcification: release rate modulation with silicone matrices via drug solubility and membrane coating.
Golomb G; Dixon M; Smith MS; Schoen FJ; Levy RJ
J Pharm Sci; 1987 Apr; 76(4):271-6. PubMed ID: 3110404
[TBL] [Abstract][Full Text] [Related]
10. AL preincubation inhibits calcification of bioprosthetic heart valve tissue in the rat subdermal model.
Webb CL; Schoen FJ; Levy RJ
ASAIO Trans; 1988; 34(3):855-9. PubMed ID: 3143392
[TBL] [Abstract][Full Text] [Related]
11. Prevention of glutaraldehyde-fixed bioprosthetic heart valve calcification by alcohol pretreatment: further mechanistic studies.
Vyavahare NR; Jones PL; Hirsch D; Schoen FJ; Levy RJ
J Heart Valve Dis; 2000 Jul; 9(4):561-6. PubMed ID: 10947050
[TBL] [Abstract][Full Text] [Related]
12. Anesthetic and ferric-magnesium ion combinations as calcium antagonists for glutaraldehyde-treated pericardial tissues.
Chandy T; Sharma CP
Clin Mater; 1994; 17(4):165-72. PubMed ID: 10155677
[TBL] [Abstract][Full Text] [Related]
13. Calcification of bovine pericardium used in cardiac valve bioprostheses. Implications for the mechanisms of bioprosthetic tissue mineralization.
Schoen FJ; Tsao JW; Levy RJ
Am J Pathol; 1986 Apr; 123(1):134-45. PubMed ID: 2421577
[TBL] [Abstract][Full Text] [Related]
14. The effects of the covalent attachment of 3-(4-hydroxy-3,5-di-tert-butylphenyl) propyl amine to glutaraldehyde pretreated bovine pericardium on structural degeneration, oxidative modification, and calcification of rat subdermal implants.
Christian AJ; Alferiev IS; Connolly JM; Ischiropoulos H; Levy RJ
J Biomed Mater Res A; 2015 Jul; 103(7):2441-8. PubMed ID: 25546235
[TBL] [Abstract][Full Text] [Related]
15. Calcification of bovine pericardium: glutaraldehyde versus No-React biomodification.
Abolhoda A; Yu S; Oyarzun JR; McCormick JR; Bogden JD; Gabbay S
Ann Thorac Surg; 1996 Jul; 62(1):169-74. PubMed ID: 8678638
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of bioprosthesis calcification due to synergistic effect of Fe/Mg ions to polyethylene glycol grafted bovine pericardium.
Vasudev SC; Chandy T; Umasankar MM; Sharma CP
J Biomater Appl; 2001 Oct; 16(2):93-107. PubMed ID: 11794726
[TBL] [Abstract][Full Text] [Related]
17. Local controlled release of 1-hydroxyethylidene diphosphonate using silicone-rubber matrices. Effects of sterilization on in vitro release and in vivo efficacy.
Johnston TP; Bove EL; Bolling SF; Schoen FJ; Boyd JA; Golomb G; Levy RJ
ASAIO Trans; 1988; 34(3):835-8. PubMed ID: 3143390
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of bioprosthetic heart valve calcification with aminodiphosphonate covalently bound to residual aldehyde groups.
Webb CL; Benedict JJ; Schoen FJ; Linden JA; Levy RJ
Ann Thorac Surg; 1988 Sep; 46(3):309-16. PubMed ID: 3137904
[TBL] [Abstract][Full Text] [Related]
19. Structural studies on bovine bioprosthetic tissues and their in vivo calcification: prevention via drug delivery.
Chandy T; Mohanty M; John A; Rao SB; Sivakumar R; Sharma CP; Valiathan MS
Biomaterials; 1996 Mar; 17(6):577-85. PubMed ID: 8652776
[TBL] [Abstract][Full Text] [Related]
20. Impact of glutaraldehyde on calcification of pericardial bioprosthetic heart valve material.
Grabenwöger M; Sider J; Fitzal F; Zelenka C; Windberger U; Grimm M; Moritz A; Böck P; Wolner E
Ann Thorac Surg; 1996 Sep; 62(3):772-7. PubMed ID: 8784007
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
